Skip to main content

Table 2 Characteristics of the patients obtained from the IMvigor210

From: A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer

Basic information

 

IMvigor210 (n = 348)

Age

Less than 1 year

176

1–2 years

99

More than 2 years

73

Gender

Female

76

Male

272

Subtype

I & II

213

III & IV

135

Response

CR/PR

68

SD/PD

230

NA

50

  1. BC bladder cancer, CR complete response, PR partial response, SD stable disease, PD progressive disease
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us